Retour
38
24
Fourchette du Jour
13,64 €
50,00 €
Fourchette 52 Semaines
13,64 €
50,00 €
Volume
2 000
Moyenne 50J / 200J
50,00 €
/
50,00 €
Clôture Précédente
50,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 97,7 | 0,4 |
| P/B | 2,4 | 2,9 |
| ROE % | 2,6 | 3,7 |
| Net Margin % | 0,7 | 3,9 |
| Rev Growth 5Y % | 31,7 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,00 €
0,00 € – 0,00 €
|
2,3 B | 0 |
| FY2027 |
1,69 €
1,66 € – 1,73 €
|
2,2 B | 1 |
| FY2026 |
1,38 €
1,36 € – 1,41 €
|
2,1 B | 1 |
Points Clés
Revenue grew 31,67% annually over 5 years — strong growth
Earnings declined -33,29% over the past year
ROE of 2,56% is below average
Debt/Equity of 0,47 — conservative balance sheet
Generating 67,36M in free cash flow
P/E of 97,65 — premium valuation
Croissance
Revenue Growth (5Y)
31,67%
Revenue (1Y)5,51%
Earnings (1Y)-33,29%
FCF Growth (3Y)44,95%
Qualité
Return on Equity
2,56%
ROIC3,17%
Net Margin0,67%
Op. Margin1,68%
Sécurité
Debt / Equity
0,47
Current Ratio2,02
Interest Coverage2,91
Valorisation
P/E Ratio
97,65
P/B Ratio2,40
EV/EBITDA42,88
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,51% | Revenue Growth (3Y) | 8,12% |
| Earnings Growth (1Y) | -33,29% | Earnings Growth (3Y) | -17,26% |
| Revenue Growth (5Y) | 31,67% | Earnings Growth (5Y) | 22,76% |
| Profitability | |||
| Revenue (TTM) | 1,88B | Net Income (TTM) | 12,55M |
| ROE | 2,56% | ROA | 1,34% |
| Gross Margin | 8,04% | Operating Margin | 1,68% |
| Net Margin | 0,67% | Free Cash Flow (TTM) | 67,36M |
| ROIC | 3,17% | FCF Growth (3Y) | 44,95% |
| Safety | |||
| Debt / Equity | 0,47 | Current Ratio | 2,02 |
| Interest Coverage | 2,91 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 97,65 | P/B Ratio | 2,40 |
| P/S Ratio | 0,65 | PEG Ratio | -2,65 |
| EV/EBITDA | 42,88 | Dividend Yield | 0,00% |
| Market Cap | 1,23B | Enterprise Value | 1,36B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,88B | 1,78B | 1,61B | 1,36B | 626,54M |
| Net Income | 12,55M | 18,81M | 18,33M | 7,40M | 5,53M |
| EPS (Diluted) | 0,49 | 0,79 | 0,77 | 0,37 | 0,35 |
| Gross Profit | 151,46M | 108,63M | 106,87M | 68,48M | 37,58M |
| Operating Income | 31,67M | 31,37M | 28,97M | 15,26M | 9,54M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 934,36M | 594,75M | 575,96M | 524,14M | 194,54M |
| Total Liabilities | 424,17M | 125,95M | 127,91M | 129,98M | 52,11M |
| Shareholders' Equity | 510,19M | 468,81M | 448,05M | 394,16M | 142,43M |
| Total Debt | 238,37M | 17,15M | 17,63M | 49,71M | 19,23M |
| Cash & Equivalents | 106,00M | 71,04M | 79,21M | 168,43M | 19,79M |
| Current Assets | 345,82M | 269,19M | 250,01M | 300,67M | 136,30M |
| Current Liabilities | 171,07M | 83,23M | 82,06M | 93,77M | 30,63M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#664 of 1024
#412 of 616
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026